More News

10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
09 Jan 2007 Xytis merges and raises $24.5M
09 Jan 2007 Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer's treatments
09 Jan 2007 Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
09 Jan 2007 PTC Therapeutics Announces Strategic Drug Discovery Collaboration With Pfizer Utilizing PTC’S Gems Technology Platform
09 Jan 2007 Seattle Genetics to Present at the JPMorgan Annual Healthcare Conference
09 Jan 2007 Cytochroma Inc. and aOvaTechnologies, Inc., Sign License Agreement.
09 Jan 2007 Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
09 Jan 2007 Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
08 Jan 2007 Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
06 Jan 2007 Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
06 Jan 2007 DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
06 Jan 2007 Provid Pharmaceuticals Inc. To Acquire Tripos Discovery Research
05 Jan 2007 Biogen Idec To Acquire Syntonix
05 Jan 2007 Elusys Announces Collaborative Research And License Agreement With Pfizer
05 Jan 2007 Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
05 Jan 2007 Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
05 Jan 2007 Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
05 Jan 2007 Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
05 Jan 2007 Ecopia Announces Agreement with Caprion to Combine Their Businesses and Launch a $30 Million Private Placement
05 Jan 2007 BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
05 Jan 2007 AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
05 Jan 2007 Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
04 Jan 2007 Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
04 Jan 2007 Sembiosys To Proceed With Abbreviated Regulatory Path For Plant- Produced Insulin After Meeting With The FDA

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top